# Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

Source: https://onco.cc/trials/nct03426904/  
OnCo record `nct03426904` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by Kyungpook National University Hospital, active but no longer recruiting.

## Summary

Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer is a phase 3, randomised interventional study registered as NCT03426904 by Kyungpook National University Hospital, with a registry enrolment figure of 708 participants, started 2020-10-23 and due to reach its primary completion in 2028-12-28. Interventions recorded: Neoadjuvant FOLFOX; Conventional adjuvant FOLFOX. Conditions listed: Colon Cancer. Primary outcome: Relapse free survival after randomization. Colorectal eligibility wording from the registry: "* Pathologically confirmed colon adenocarcinoma (\> 15 cm from the anal verge)". Sites: South Korea. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT03426904
- Phase: 3
- Setting: Neoadjuvant Chemotherapy for Non-metastatic Locally Advanced Colon Cancer: A Prospective Multicenter Randomized Controlled Trial
- Sponsor: Kyungpook National University Hospital
- Enrolled: 708

## Sources

- ClinicalTrials.gov NCT03426904: https://clinicaltrials.gov/study/NCT03426904

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct03426904.json